http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05117289-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
filingDate 1992-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0624bbae6b7bfee4d3bd992d4fad1639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65a5d3ab7b3078a37044d46ae5086d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80c1a2b336f195add408a94e658124dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e63234d0573b9dc9ed66f8b47ad12f
publicationDate 1993-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H05117289-A
titleOfInvention Macrolide antibiotic crystals and solvates
abstract (57) Abstract: Acetone, 1-butanol, 1-propanol, and 2-propanol solvates of dilithromycin for isolating type II dilithromycin are provided. Also provided is a method for isolating dilithromycin type II from its solvate or dilithromycin type I. Further provided are methods for obtaining type II dilithromycin from unsolvated dilithromycin. [Effect] Since type II dilithromycin is stable at ambient temperature, it can be a simple and efficient and economical means for isolation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012107075-A
priorityDate 1991-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426534

Total number of triples: 32.